v3.26.3
Condensed Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Operating expenses:        
Research and development $ 22,668 $ 31,450 $ 268,410 $ 107,607
General and administrative 37,419 9,681 83,057 24,717
Total operating expenses 60,087 41,131 351,467 132,324
Loss from operations (60,087) (41,131) (351,467) (132,324)
Interest and other income 5,947 4,199 17,752 9,907
Interest expense (3,188) 0 (4,023) 0
Total other income, net 2,759 4,199 13,729 9,907
Net loss $ (57,328) $ (36,932) $ (337,738) $ (122,417)
Net loss per share attributable to common stockholders - basic (in USD per share) $ (0.64) $ (0.52) $ (3.95) $ (1.94)
Net loss per share attributable to common stockholders - diluted (in USD per share) $ (0.64) $ (0.52) $ (3.95) $ (1.94)
Weighted-average shares used in computing net loss per share attributable to common stockholders - basic (in shares) 88,986,795 70,594,504 85,538,811 63,133,634
Weighted-average shares used in computing net loss per share attributable to common stockholders - diluted (in shares) 88,986,795 70,594,504 85,538,811 63,133,634